Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination
Colomer Pache, M.; Arnedo Pena, A.
Medicina Clinica 91(17): 649-652
1988
ISSN/ISBN: 0025-7753 PMID: 3230970 Document Number: 325156
A measles epidemic developed in Gatova (Castellon) between June 7 and July 14, 1987, involving 46 individuals with an attack rate of 54.8% in susceptible subjects and 8.0% in the general population. 80.4% of cases developed in schoolchildren, and the patients' mean age was 10.5 .+-. 4.4 years. Only 4.4% of the patients had received measles vaccination. The efficacy of measles vaccination was estimated to be 82.7% (95% confidence intervals: 37.3% and 95.2%). Recommendations for the eradication of measles are given.
Document emailed within 1 workday
Related Documents
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771Babakura, B.; Nomhwange, T.; Jean Baptiste, A.E.; Dede, O.; Taiwo, L.; Abba, S.; Soyemi, M.; Idowu, A.M.; Terna Richard, M.; Braka, F.; Oteri, J.; Shuaib, F. 2021: The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: a case study of 2017/18 measles campaign in Borno state, Nigeria Vaccine 39(Suppl 3): C66-C75
Benn, C.S.; Martins, Cário.L.; Andersen, A.; Fisker, A.B.; Whittle, H.C.; Aaby, P. 2020: Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival Frontiers in Pediatrics 8: 20
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects Ugeskrift for Laeger 147(38): 3013-3017
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. II. Socio-economic analysis Ugeskrift for Laeger 147(38): 3017-3022
Semba, R.D.; Munasir, Z.; Beeler, J.; Akib, A.; Muhilal; Audet, S.; Sommer, A. 1995: Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345(8961): 1330-1332
Balé, C.; Garly, M-Lill.; Martins, C.; Nielsen, J.; Whittle, H.; Aaby, P. 2011: Risk factors for measles in young infants in an urban African area with high measles vaccination coverage Pediatric Infectious Disease Journal 30(8): 689-693
Lowther, S.A.; Curriero, F.C.; Kalish, B.T.; Shields, T.M.; Monze, M.; Moss, W.J. 2009: Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey Lancet 373(9668): 1025-1032
Barabash, M.A.; Iarovoĭ, P.I. 1971: Effect of mass vaccination on the measles epidemic process in Moldavia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(3): 107-110
Alberti, K.P.; King, L.A.; Burny, M-Eve.; Ilunga, B.Kebela.; Grais, R.F. 2010: Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005-2006 International health 2(1): 65-68
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Tohme, R.A.; François, J.; Wannemuehler, K.; Magloire, R.; Danovaro-Holliday, M.Carolina.; Flannery, B.; Cavallaro, K.F.; Fitter, D.L.; Purcell, N.; Dismer, A.; Tappero, J.W.; Vertefeuille, J.F.; Hyde, T.B. 2014: Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination Tropical Medicine and International Health: Tm and Ih 19(9): 1105-1115
Bennett, J.V.; Fernandez de Castro, J.; Valdespino-Gomez, J.Luis.; Garcia-Garcia, M.de.Lourdes.; Islas-Romero, R.; Echaniz-Aviles, G.; Jimenez-Corona, A.; Sepulveda-Amor, J. 2002: Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bulletin of the World Health Organization 80(10): 806-812
Aaby, P.; Bhuiya, A.; Nahar, L.; Knudsen, K.; de Francisco, A.; Strong, M. 2003: The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh International Journal of Epidemiology 32(1): 106-116
Sharma, R.S. 1988: An epidemiological study of measles epidemic in district Bhilwara, Rajasthan Journal of Communicable Diseases 20(4): 301-311
Formento, J.A.; Gallego, R.; Moya, A.; Arenas, A.; Beltrán, F.; Castellanos, M.J. 1992: Measles epidemic in Huesca. Study of cases in a health center Atencion Primaria 10(6): 849
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
Kotb, M.M.; Khella, A.K.; Allam, M.F. 1999: Evaluation of the effectiveness of routine measles vaccination: case-control study Journal of the Egyptian Public Health Association 74(1-2): 59-68
Bhagyalaxmi, A.; Kedia, G.; Rawal, V.S. 2007: Study of incidence of measles and vaccination coverage in Ahmedabad urban slums Indian Journal of Public Health 51(1): 52-53
Doźić, S. 1973: Measles encephalitis with multinuclear giant cells and inclusion bodies. Study of the primary viral origin of measles encephalitis Srpski Arhiv Za Celokupno Lekarstvo 100(4): 581-590